about
Fluorescence in situ hybridization in surgical pathology: principles and applications.15-Deoxy-Δ12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction.miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genesExpression of PAX8 Target Genes in Papillary Thyroid Carcinoma.Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy.Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer.Identification of novel diagnostic biomarkers for thyroid carcinoma.MiR-144-3p promotes the tumor growth and metastasis of papillary thyroid carcinoma by targeting paired box gene 8.Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology.
P2860
Q33593910-B1948208-B7DB-4F09-8D82-DE1E4E670D9DQ33597917-F10C2DC2-AA7F-4BFD-83D1-BB04C05824C7Q33709554-A695C6EF-EE8E-444A-ADFA-4C2559A9B234Q35906347-D52598D3-8A6E-4B4B-BC49-EE7A2E290B0FQ36036551-1714945E-0709-4DC5-9C37-6A33A6E854C8Q36562038-96FBBF28-2085-4FFF-9633-4CFAB7CAD3F4Q37362760-6D91D2C9-0D50-4765-9380-F2B7256D8487Q37520401-697082A9-E087-4B25-9BA3-DF556B3BEA2FQ38844362-B284AC91-95E9-4818-8E95-A4DB2DC6D9BFQ39002421-9C9A7D3D-FE21-4CCA-8D13-D5D5294ECC22Q46073511-1B72EA92-B699-4832-9BD3-94F2DDAABD95Q49475238-4F5F2C3A-62A7-4754-BDF4-3C0AAE4C77CBQ50017200-77521957-79D3-4075-B3FE-9078DE37EF8DQ52597712-1F67167F-4E7D-4D79-AE63-870FAEB76850Q52778675-A4607412-DB5C-4C11-996B-28D20AC2373EQ54601556-177ACC78-6CFD-4A39-94A8-C6C4C5D8BF33
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@ast
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@en
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@nl
type
label
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@ast
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@en
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@nl
prefLabel
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@ast
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@en
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@nl
P2860
P3181
P356
P1476
Pax-8-PPAR-γ fusion protein in thyroid carcinoma
@en
P2093
Priyadarshini Raman
Ronald J Koenig
P2860
P2888
P304
P3181
P356
10.1038/NRENDO.2014.115
P407
P577
2014-10-01T00:00:00Z